Compare LZ & VOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LZ | VOR |
|---|---|---|
| Founded | 2001 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2012 | 2021 |
| Metric | LZ | VOR |
|---|---|---|
| Price | $4.49 | $19.15 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $6.38 | ★ $39.00 |
| AVG Volume (30 Days) | ★ 2.5M | 636.5K |
| Earning Date | 11-04-2026 | 10-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $756,043,000.00 | N/A |
| Revenue This Year | $5.76 | N/A |
| Revenue Next Year | $3.70 | N/A |
| P/E Ratio | $57.06 | ★ N/A |
| Revenue Growth | ★ 10.88 | N/A |
| 52 Week Low | $4.50 | $7.21 |
| 52 Week High | $10.51 | $26.00 |
| Indicator | LZ | VOR |
|---|---|---|
| Relative Strength Index (RSI) | 29.63 | 48.50 |
| Support Level | N/A | $17.62 |
| Resistance Level | $6.65 | $20.11 |
| Average True Range (ATR) | 0.38 | 1.29 |
| MACD | -0.13 | -0.09 |
| Stochastic Oscillator | 0.73 | 44.48 |
LegalZoom.com Inc is an online provider of services that meet the legal needs of small businesses and consumers in the United States. The company also offers services that include ongoing compliance and tax advice and filings, business licenses, accounting, virtual mailbox and e-signature solutions, trademark filings, and estate plans.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.